Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Huangshan Capsule is a China-based publicly traded manufacturer of pharmaceutical capsule excipients focused on empty hard capsules rather than therapeutic drug development. Founded in 1989, the company produces gelatin empty capsules, enteric hollow capsules, vegetable enteric capsules, colon-soluble capsules, hydroxypropyl methyl cellulose capsules, pullulan capsules, and related dosage-form packaging products for the pharmaceutical and health products industries. It operates large-scale GMP-compliant capsule manufacturing facilities in Jingde County, Anhui, and markets its products across China. The company is notable as one of the earliest listed Chinese companies with empty capsules as its core business and generates revenue from commercial sales of capsule products rather than from an R&D drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Huangshan Capsule.